In the current trading session, Mereo Biopharma Group Plc ADR’s (MREO) stock is trading at the price of $1.61, a fall of -1.74% over last night’s close. So, the stock is trading at a price that is -67.90% less than its 52-week high of $5.02 and 9.63% better than its 52-week low of $1.47. Based on the past 30-day period, the stock price is -13.23% below the high and +11.56% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, MREO’s SMA-200 is $2.7167.
It is also essential to consider MREO stock ratios like the price-to-sales ratio, which is 502.41 for the last year.MREO’s price to book ratio for the most recent quarter was 4.73, resulting in an 4.57 price to cash per share for the period.
How does Mereo Biopharma Group Plc ADR (MREO) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 9 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 4.67 in simple terms.
Mereo Biopharma Group Plc ADR (MREO): Earnings History
If we examine Mereo Biopharma Group Plc ADR’s recent earnings history, in the last quarter ended on 6/30/2025, it posted adjusted earnings per share of -$0.01, slashing the consensus of -$0.01. In other words, it topped the consensus by -$0.01, resulting in a -65.78% surprise. In the 3 months period before the previous quarter which was closed on 6/30/2025, the stock recorded adjusted earnings per share of -$0.01 in contrast with the Outlook of -$0.01. That was a difference of -$0.01 and a surprise of -65.78%.
Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Ownership Details
I will give a breakdown of the key shareholders in Mereo Biopharma Group Plc ADR (MREO). Recent figures show that the company’s insiders hold 0.96% of shares. A total of 92 institutional investors hold shares in the company, making 69.07% of its stock and 69.74% of its float.
Jun 30, 2025 , it was reported that the Company’s largest institutional holder is Janus Henderson Group PLC holding total of 17.69 shares that make 11.12% of the company’s total number of shares and are currently priced at 28.48 million.
The securities firm Rubric Capital Management LP holds 15.31 shares of MREO, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 9.63% , and the holding percentage of shares is valued at 24.64 million.
An overview of Mereo Biopharma Group Plc ADR’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Mereo Biopharma Group Plc ADR (MREO) traded 1,390,034 shares per day, with a moving average of $1.6685 and price change of -0.2250. With the moving average of $2.1293 and a price change of -1.0100, about 2,558,792 shares changed hands on average over the past 50 days. Finally, MREO’s 100-day average volume is 2,021,043 shares, alongside a moving average of $2.2211 and a price change of -0.7700.
